nicholas prediction, page-12

wow, this one's died a death in the meltdown ... even really good news would get squashed now. long way away from that high of .38 only a matter of weeks ago.
certainly hope they can get some decent revenue by years end to start a sustained re-rate, but no doubt its going to take time now. one positive is that the oppies have held up well; virtually no selling even when bids at around .11 have been offered. I need a few more to even off my holding, but ords representing the best buy at present in my view. management maintaining the line that next six months will mark the coming of age for medicvision. let's hope they are right. any thoughts ?